{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:16:43Z","timestamp":1788931003154,"version":"build-2803163510"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>In this study, we report an 84-year-old female proband in a Japanese family with familial hypocalciuric hypercalcemia (FHH) caused by an R648stop mutation in the extracellular calcium-sensing receptor (CaR) gene. At the age of 71 years, she presented with hypercalcemia (11.4 mg\/dl), hypocalciuria (Cca\/Ccr = 0.003), hypermagnesemia (2.9 mg\/dl), and a high-serum parathyroid hormone (PTH) level (midregion PTH, 3225 [160\u2013520] pg\/ml). At the age of 74 years, a family screening was carried out and revealed a total of 9 hypercalcemic individuals (all intact PTH values &amp;lt;62 pg\/dl) among 17 family members tested, thus, being diagnosed as FHH. Two and one-half of three clearly enlarged parathyroid glands were resected, because persistently high PTH levels (intact PTH, 292 pg\/ml; midregion PTH, 5225 pg\/ml) and the presence of a markedly enlarged parathyroid gland by several imaging modalities (ultrasonography, computed tomography [CT], magnetic resonance imaging [MRI], and subtraction scintigraphy) suggested coexistent primary hyperparathyroidism (pHPT); however, hypercalcemia persisted postoperatively. Histological and immunohistochemical examination revealed that the resected parathyroid glands showed lipohyperplasia as well as normally expressed Ki67, vitamin D receptor (VDR), and the CaR. Sequence analysis disclosed that the proband and all affected family members had a heterozygous nonsense (R648stop) mutation in the CaR gene. This mutation is located in the first intracellular loop; thus, it would be predicted to produce a truncated CaR having only one transmembrane domain (TMD) and lacking its remaining TMDs, intracellular loops, and C-terminal tail. Western analysis of biotinylated HEK293 cells transiently transfected with this mutant receptor showed cell surface expression of the truncated protein at a level comparable with that of the wild-type CaR. The mutant receptor, however, exhibited no increase in intracellular free calcium concentration (Ca2+i) when exposed to high extracellular calcium concentrations (Ca2+o). The proband's clinical course was complicated because of associated renal tubular acidosis (RTA) and nephrotic syndrome. However, it was unclear whether their association affected the development of elevated serum PTH and parathyroid gland enlargement. This report is the first to show that an R648stop CaR mutation yields a truncated receptor that is expressed on the cell surface but is devoid of biological activity, resulting in FHH.<\/jats:p>","DOI":"10.1359\/jbmr.2002.17.12.2174","type":"journal-article","created":{"date-parts":[[2006,4,26]],"date-time":"2006-04-26T21:00:53Z","timestamp":1146085253000},"page":"2174-2182","source":"Crossref","is-referenced-by-count":20,"title":["Familial Hypocalciuric Hypercalcemia Caused by an R648stop Mutation in the Calcium-Sensing Receptor Gene"],"prefix":"10.1093","volume":"17","author":[{"given":"Mika","family":"Yamauchi","sequence":"first","affiliation":[{"name":"Division of Endocrinology\/Metabolism, Neurology, and Hematology\/Oncology, Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshitsugu","family":"Sugimoto","sequence":"additional","affiliation":[{"name":"Division of Endocrinology\/Metabolism, Neurology, and Hematology\/Oncology, Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Division of Endocrinology\/Metabolism, Neurology, and Hematology\/Oncology, Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shozo","family":"Yano","sequence":"additional","affiliation":[{"name":"Division of Endocrinology\/Metabolism, Neurology, and Hematology\/Oncology, Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junning","family":"Wang","sequence":"additional","affiliation":[{"name":"Endocrine-Hypertension Division and Membrane Biology Program, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Bai","sequence":"additional","affiliation":[{"name":"Endocrine-Hypertension Division and Membrane Biology Program, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward M.","family":"Brown","sequence":"additional","affiliation":[{"name":"Endocrine-Hypertension Division and Membrane Biology Program, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Chihara","sequence":"additional","affiliation":[{"name":"Division of Endocrinology\/Metabolism, Neurology, and Hematology\/Oncology, Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,12,2]]},"reference":[{"key":"2024013019054374000_bib1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/366575a0","article-title":"Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid","volume":"366","author":"Brown","year":"1993","journal-title":"Nature"},{"key":"2024013019054374000_bib2","first-page":"289","article-title":"The calcium-sensing receptor: A window into the physiology and pathophysiology of mineral ion metabolism","volume":"17","author":"Chattopadhyay","year":"1996","journal-title":"Endocr Rev"},{"key":"2024013019054374000_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1054-3589(08)60113-1","article-title":"G protein-coupled extracellular Ca2+ (Ca2+o)-sensing receptor (CaR): Roles in cell signaling and control of diverse cellular functions","volume":"47","author":"Yamaguchi","year":"2000","journal-title":"Adv Pharmacol"},{"key":"2024013019054374000_bib4","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/0092-8674(93)90617-Y","article-title":"Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism","volume":"75","author":"Pollak","year":"1993","journal-title":"Cell"},{"key":"2024013019054374000_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s004390050174","article-title":"The Ca(2+)-sensing receptor gene (PCAR1) mutation T151M in isolated autosomal dominant hypoparathyroidism","volume":"98","author":"Lovlie","year":"1996","journal-title":"Hum Genet"},{"key":"2024013019054374000_bib6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ng1194-303","article-title":"Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation","volume":"8","author":"Pollak","year":"1994","journal-title":"Nat Genet"},{"key":"2024013019054374000_bib7","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1172\/JCI117062","article-title":"Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype","volume":"93","author":"Pollak","year":"1994","journal-title":"J Clin Invest"},{"key":"2024013019054374000_bib8","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1172\/JCI119851","article-title":"The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor","volume":"100","author":"Wada","year":"1997","journal-title":"J Clin Invest"},{"key":"2024013019054374000_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/ng1295-389","article-title":"A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism","volume":"11","author":"Ho","year":"1995","journal-title":"Nat Genet"},{"key":"2024013019054374000_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000185516","article-title":"Mutations in the calcium-sensing receptor and their clinical implications","volume":"48","author":"Brown","year":"1997","journal-title":"Horm Res"},{"key":"2024013019054374000_bib11","first-page":"4789","article-title":"Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism","volume":"85","author":"Cetani","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013019054374000_bib12","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0002-9343(84)90852-0","article-title":"Parathyroid glands in familial benign hypercalcemia (familial hypocalciuric hypercalcemia)","volume":"76","author":"Law","year":"1984","journal-title":"Am J Med"},{"key":"2024013019054374000_bib13","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/bjs.1800730310","article-title":"Familial hypocalciuric hypercalcaemia as a differential diagnosis of hyperparathyroidism: Studies in a large kindred and a review of surgical experience in the condition","volume":"73","author":"Lyons","year":"1986","journal-title":"Br J Surg"},{"key":"2024013019054374000_bib14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0046-8177(81)80123-2","article-title":"The parathyroid glands in familial hypocalciuric hypercalcemia","volume":"12","author":"Thorgeirsson","year":"1981","journal-title":"Hum Pathol"},{"key":"2024013019054374000_bib15","first-page":"13","article-title":"A novel mutation in the calcium-sensing receptor gene in a Chinese subject with persistent hypercalcemia and hypocalciuria","volume":"86","author":"Jap","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013019054374000_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/000456329002700114","article-title":"Immunoradiometric assay for intact human parathyroid hormone: Characteristics, clinical application and comparison with a radio-immunoassay","volume":"27","author":"Frolich","year":"1990","journal-title":"Ann Clin Biochem"},{"key":"2024013019054374000_bib17","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/clinchem\/33.8.1364","article-title":"Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia","volume":"33","author":"Nussbaum","year":"1987","journal-title":"Clin Chem"},{"key":"2024013019054374000_bib18","first-page":"807","article-title":"Clinical studies using a highly sensitive radioimmunoassay for mid-region and carboxy terminus of parathyroid hormone in normal, hypo- and hypercalcemic states (in Japanese)","volume":"65","author":"Fukase","year":"1989","journal-title":"Nippon Naibunpi Gakkai Zasshi"},{"key":"2024013019054374000_bib19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1172\/JCI108077","article-title":"Metabolism in immunoreactive parathyroid hormone in the dog. The role of the kidney and the effects of chronic renal disease","volume":"56","author":"Hruska","year":"1975","journal-title":"J Clin Invest"},{"key":"2024013019054374000_bib20","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1359\/jbmr.1997.12.11.1780","article-title":"Monoclonal antibodies against synthetic peptides corresponding to the extracellular domain of the human Ca2+ receptor: Characterization and use in studying concanavalin A inhibition","volume":"12","author":"Goldsmith","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2024013019054374000_bib21","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1111\/j.1523-1755.2000.00370.x","article-title":"Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism","volume":"58","author":"Yano","year":"2000","journal-title":"Kidney Int"},{"key":"2024013019054374000_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/43.1.7822770","article-title":"A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: Use of microwave oven heating to block antibody crossreactivity and retrieve antigens","volume":"43","author":"Lan","year":"1995","journal-title":"J Histochem Cytochem"},{"key":"2024013019054374000_bib23","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/29.4.6166661","article-title":"Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures","volume":"29","author":"Hsu","year":"1981","journal-title":"J Histochem Cytochem"},{"key":"2024013019054374000_bib24","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1046\/j.1365-2265.1999.00729.x","article-title":"An adult patient with severe hypercalcaemia and hypocalciuria due to a novel homozygous inactivating mutation of calcium-sensing receptor","volume":"50","author":"Chikatsu","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024013019054374000_bib25","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1172\/JCI118335","article-title":"Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism","volume":"96","author":"Pearce","year":"1995","journal-title":"J Clin Invest"},{"key":"2024013019054374000_bib26","doi-asserted-by":"crossref","first-page":"19537","DOI":"10.1074\/jbc.271.32.19537","article-title":"Expression and characterization of inactivating and activating mutations in the human Ca2+o-sensing receptor","volume":"271","author":"Bai","year":"1996","journal-title":"J Biol Chem"},{"key":"2024013019054374000_bib27","doi-asserted-by":"crossref","first-page":"23605","DOI":"10.1074\/jbc.273.36.23605","article-title":"Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells","volume":"273","author":"Bai","year":"1998","journal-title":"J Biol Chem"},{"key":"2024013019054374000_bib28","first-page":"1843","article-title":"Sodium bicarbonate loading test and urine-blood carbon dioxide partial pressure for the diagnosis of renal tubular acidosis (in Japanese)","volume":"43","author":"Nagai","year":"1985","journal-title":"Nippon Rinsho"},{"key":"2024013019054374000_bib29","first-page":"1598","article-title":"Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism","volume":"81","author":"Kifor","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013019054374000_bib30","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ki.1997.41","article-title":"Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism","volume":"51","author":"Gogusev","year":"1997","journal-title":"Kidney Int"},{"key":"2024013019054374000_bib31","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2265.2000.01081.x","article-title":"Reduced vitamin D receptor expression in parathyroid adenomas: Implications for pathogenesis","volume":"53","author":"Sudhaker Rao","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024013019054374000_bib32","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1172\/JCI118987","article-title":"Functional characterization of calcium-sensing receptor mutations expressed in human embryonic kidney cells","volume":"98","author":"Pearce","year":"1996","journal-title":"J Clin Invest"},{"key":"2024013019054374000_bib33","doi-asserted-by":"crossref","first-page":"511","DOI":"10.7326\/0003-4819-102-4-511","article-title":"Familial benign hypercalcemia (hypocalciuric hypercalcemia). Clinical and pathogenetic studies in 21 families","volume":"102","author":"Law","year":"1985","journal-title":"Ann Intern Med"},{"key":"2024013019054374000_bib34","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00019606-200112000-00006","article-title":"Inactivating mutations of calcium-sensing receptor results in parathyroid lipohyperplasia","volume":"10","author":"Fukumoto","year":"2001","journal-title":"Diagn Mol Pathol"},{"key":"2024013019054374000_bib35","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/0046-8177(94)90064-7","article-title":"Nodular foci in parathyroid adenomas and hyperplasias: An immunohistochemical analysis of proliferative activity","volume":"25","author":"Loda","year":"1994","journal-title":"Hum Pathol"},{"key":"2024013019054374000_bib36","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1046\/j.1523-1755.1999.00396.x","article-title":"Expression of PRAD1\/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma","volume":"55","author":"Tominaga","year":"1999","journal-title":"Kidney Int"},{"key":"2024013019054374000_bib37","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1056\/NEJM198706183162504","article-title":"Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure","volume":"316","author":"Korkor","year":"1987","journal-title":"N Engl J Med"},{"key":"2024013019054374000_bib38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0025-6196(12)60766-6","article-title":"High-resolution parathyroid ultrasonography in familial benign hypercalcemia (familial hypocalciuric hypercalcemia)","volume":"59","author":"Law","year":"1984","journal-title":"Mayo Clin Proc"},{"key":"2024013019054374000_bib39","doi-asserted-by":"crossref","first-page":"31355","DOI":"10.1074\/jbc.272.50.31355","article-title":"The carboxyl terminus of the human calcium receptor. Requirements for cell-surface expression and signal transduction","volume":"272","author":"Ray","year":"1997","journal-title":"J Biol Chem"},{"key":"2024013019054374000_bib40","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/(SICI)1096-8628(19970808)71:2<202::AID-AJMG16>3.0.CO;2-I","article-title":"Neonatal severe hyperparathyroidism, secondary hyperparathyroidism, and familial hypocalciuric hypercalcemia: Multiple different phenotypes associated with an inactivating Alu insertion mutation of the calcium-sensing receptor gene","volume":"71","author":"Cole","year":"1997","journal-title":"Am J Med Genet"},{"key":"2024013019054374000_bib41","first-page":"880","article-title":"Insertion of an Alu sequence in the Ca(2+)-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism","volume":"56","author":"Janicic","year":"1995","journal-title":"Am J Hum Genet"},{"key":"2024013019054374000_bib42","first-page":"2042","article-title":"Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor","volume":"85","author":"Carling","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013019054374000_bib43","first-page":"234","author":"Lee","year":"1976"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2Fjbmr.2002.17.12.2174","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/17\/12\/2174\/56469290\/5650171210.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/17\/12\/2174\/56469290\/5650171210.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T15:04:16Z","timestamp":1710342256000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/17\/12\/2174-2182\/7592276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12,1]]},"references-count":43,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2009,12,2]]},"published-print":{"date-parts":[[2002,12,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.2002.17.12.2174","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2002,12,1]]},"published":{"date-parts":[[2002,12,1]]}}}